| Income Statement |
| Total Revenue | 2.07B |
|
| Revenues (USD) | 299.82M |
| Cost of Revenue | 298.22M |
| Gross Profit | 1.77B |
| Operating Expenses | 1.15B |
| Research and Development Expense | 423.80M |
| Selling, General and Administrative Expense | 724.24M |
| Operating Income | 623.63M |
| Income Tax Expense | 298.95M |
| Net Income | 1.16B |
| Net Income Common Stock | 1.16B |
| Net Income Common Stock (USD) | 167.64M |
| Consolidated Income | 1.13B |
| Net Income to Non-Controlling Interests | -30.92M |
| Earnings per Basic Share | 2.50 |
| Earnings per Basic Share (USD) | 0.36 |
| Earnings per Diluted Share | 2.50 |
| Earning Before Interest & Taxes (EBIT) | 1.46B |
| Earning Before Interest & Taxes (USD) | 210.96M |
| Weighted Average Shares | 927.66M |
| Weighted Average Shares Diluted | 948.09M |
| Balance Sheet |
| Cash and Equivalents | 3.35B |
| Cash and Equivalents (USD) | 485.77M |
| Investments | 20.39B |
| Investments Current | 17.15B |
| Investments Non-Current | 3.25B |
| Trade and Non-Trade Receivables | 47.83M |
| Current Assets | 20.99B |
| Property, Plant & Equipment Net | 1.28B |
| Total Assets | 25.63B |
| Debt Current | 68.52M |
| Total Debt | 123.60M |
| Current Liabilities | 4.85B |
| Debt Non-Current | 55.07M |
| Total Liabilities | 5.09B |
| Shareholders Equity | 20.54B |
| Shareholders Equity (USD) | 2.98B |
| Assets Non-Current | 4.65B |
| Total Debt (USD) | 17.91M |
| Deferred Revenue | 3.56B |
| Goodwill and Intangible Assets | 102.79M |
| Inventory | 2.33M |
| Liabilities Non-Current | 243.89M |
| Trade and Non-Trade Payables | 136.19M |
| Tax Assets | 18.71M |
| Tax Liabilities | 188.81M |
| Cash Flow |
| Net Cash Flow from Financing | -359.33M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -753.10M |
| Net Cash Flow from Investing | -1.55B |
| Net Cash Flow from Operations | 1.19B |
| Effect of Exchange Rate Changes on Cash | -31.03M |